GGrantIndex
Sort

25,944 grants matching neurodegeneration

Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics

$4,638,911
Ed Lein · Allen Institute · U19 · FY2024 · AG

ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE

$4,621,257
Reisa A. Sperling · University Of California, San Diego · U19 · FY2013 · AG

Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis

$4,538,275
Lennart Mucke · J. David Gladstone Institutes · RF1 · FY2019 · AG

NAPS2 Administrative Core

$4,538,119
Yo-El S Ju · Washington University · U19 · FY2021 · AG

Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics

$4,510,534
Ed Lein · Allen Institute · U19 · FY2021 · AG

A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients

$4,489,665
Hans Joerg Moebius · Athira Pharma, Inc. · R01 · FY2021 · AG

Procurement and Characterization of Postmortem Brain Tissue

$4,484,811
Stefano Marenco · National Institute Of Mental Health · ZIC · FY2022 · MH

Harnessing Proteins as Drugs: the Protectome of Cancer- and Aging-Prevention Proteins

$4,480,000
Susan M. Rosenberg · Baylor College Of Medicine · DP1 · FY2020 · AG

PET Radiopharmaceutical Sciences

$4,463,105
Victor W Pike · National Institute Of Mental Health · ZIA · FY2014 · MH

New Mexico Alzheimer's Disease Research Center

$4,422,177
Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P30 · FY2024 · AG

PET Radiopharmaceutical Sciences

$4,411,702
Victor W Pike · National Institute Of Mental Health · ZIA · FY2025 · MH

Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration

$4,403,626
Christopher Ramsden · National Institute On Aging · ZIA · FY2020 · AG

Procurement and Characterization of Postmortem Brain Tissue

$4,384,200
Susan Amara · National Institute Of Mental Health · ZIC · FY2014 · MH

New Mexico Alzheimer's Disease Research Center

$4,367,886
Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · P30 · FY2025 · AG

Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)

$4,355,918
Thomas T Perls · Boston University Medical Campus · U19 · FY2022 · AG

PET Radiopharmaceutical Sciences

$4,341,347
Victor W Pike · National Institute Of Mental Health · ZIA · FY2013 · MH

Core D: Neuroimaging Core

$4,326,517
Bradley T Christian · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AG

The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease

$4,308,552
Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2022 · AG

Metformin in Alzheimer's dementia Prevention (MAP)

$4,296,110
Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2019 · AG

Center for Alzheimer's and Related Dementias (CARD): iPSC Neurodegenerative Diseases Initiative

$4,290,603
Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG

Center without Walls for Imaging Proteinopathies with PET (CW2IP2)

$4,279,279
Robert H Mach · University Of Pennsylvania · U19 · FY2021 · NS

Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)

$4,278,987
Thomas T Perls · Boston University Medical Campus · U19 · FY2021 · AG

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease

$4,277,120
Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · AG

Consequences of Exposure to Repetitive Head Impacts Across the Lifespan

$4,269,339
Ann Carolyn McKee · Boston University Medical Campus · RF1 · FY2025 · NS

NAPS2 Administrative Core

$4,251,441
Yo-El S Ju · Washington University · U19 · FY2023 · AG